Zobrazeno 1 - 10
of 59
pro vyhledávání: '"M. Raluy-Callado"'
Publikováno v:
Value in Health. 23:S670
Publikováno v:
Value in Health
Objectives: In March 2020, coronavirus (COVID-19) was declared a pandemic by the World Health Organization (WHO) Globally, 11 million cases and 500,00 deaths have been reported as of July 2020 Healthcare services were put under extreme pressure leadi
Publikováno v:
Value in Health. 23:S475
Publikováno v:
International Journal of Clinical Practice
Summary Aims To investigate the rates and risk of hospitalisations in patients with type 2 diabetes (T2D) mellitus in England. Methods This retrospective population-based cohort study used computerised records from the General Practice Research Datab
Autor:
Raza Alikhan, C. Colby, N. Hill, G. Stynes, Beth L. Nordstrom, R. Donaldson, Sreeram V Ramagopalan, M. Raluy-Callado, S. Graham, Raymond J. Carroll
Publikováno v:
Value in Health. 21:S112
Publikováno v:
Journal of Crohn's and Colitis. 12:S076-S076
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Donaldson, E. Zhu, M. Raluy-Callado, J. Birt, D. Ilo, P. Graham-Clarke, Mike Kirby, David Neasham, R. Sadasivan
Publikováno v:
International journal of clinical practice. 69(8)
Summary Aims The aim of this study was to assess patient characteristics, medication treatment patterns and healthcare resource utilization among men with existing erectile dysfunction (ED) or benign prostatic hyperplasia (BPH), who are newly diagnos
Publikováno v:
Value in Health. 20:A632
Publikováno v:
Journal of Crohn's and Colitis. 11:S318-S318
Background: This study aimed to compare IBD-related flare, hospitalisations, and corticosteroid use within one year of initiation of vedolizumab (VDZ) versus infliximab (IFX) among biologic-naive IBD patients in a real-world setting.Methods: We under